Ketamine Clinics in Arizona
25 providers across 11 cities
Browse by City
Arizona has a growing ketamine therapy market concentrated in the Phoenix-Scottsdale metro and Tucson. The state's mix of standalone ketamine infusion clinics, integrative wellness centers, and psychiatry practices gives patients a range of provider options and clinical approaches. Arizona goes beyond federal mental health parity requirements under Jake's Law (SB 1523, 2020), which grants the state Division of Insurance explicit enforcement authority over MHPAEA compliance and requires insurers to submit triennial parity reports — making Arizona one of 10 states solely responsible for enforcing parity in individual and small-group insurance markets. In June 2025, Arizona signed SB 1555, a conditional trigger law that would allow FDA-approved psilocybin prescribing if the DEA reschedules psilocybin before 2031.
Modalities Available
Arizona clinics offer IV ketamine infusion, intramuscular (IM) injection, Spravato (esketamine) at certified REMS centers, and oral/sublingual ketamine, including telehealth-based at-home programs. IV infusion is the most prevalent modality, particularly in Phoenix, Scottsdale, and Gilbert. Spravato is available at multiple REMS-certified centers in the Phoenix metro — AHCCCS (Arizona's Medicaid program) covers esketamine with prior authorization, and Spravato received FDA approval as a standalone monotherapy for treatment-resistant depression in January 2025. BCBS of Arizona has a formal Spravato coverage policy. The DEA's telehealth prescribing extension through December 31, 2026 allows patients to access at-home sublingual ketamine through telehealth providers without an in-person visit.
Cost & Pricing
IV ketamine infusions in Arizona typically range from $375–$650 per session. The lowest documented price is $375 at Mind Body Centers in Gilbert. Scottsdale-area clinics consistently charge $500–$650, reflecting premium market positioning. Most patients complete a standard 6-infusion induction protocol, with package pricing available at most providers. Spravato is available through most major insurers with prior authorization at substantially reduced out-of-pocket costs.
Insurance Coverage
Arizona is one of 10 states solely responsible for enforcing the Mental Health Parity and Addiction Equity Act (MHPAEA) in individual and small-group insurance markets. Jake's Law (SB 1523, 2020) gives the state Division of Insurance explicit authority to investigate and sanction MHPAEA violations, and requires insurers to submit triennial parity compliance reports. AHCCCS (Arizona Medicaid) covers esketamine (Spravato) with prior authorization. BCBS of Arizona has a formal Spravato coverage policy. IV ketamine infusions are generally not covered by insurance and are paid out-of-pocket. Many clinics accept HSA and FSA payments.
Psilocybin Legislation
In June 2025, Arizona signed SB 1555, a conditional trigger law that would allow licensed physicians to prescribe FDA-approved psilocybin if the DEA reschedules psilocybin to Schedule II or lower before 2031. The state also established a Psilocybin Advisory Board to study psilocybin therapy and provide policy recommendations. While psilocybin therapy is not yet available in Arizona, these developments position the state to move quickly if federal rescheduling occurs.
Conditions Treated
Arizona ketamine clinics treat treatment-resistant depression, anxiety disorders, PTSD, OCD, bipolar depression, suicidal ideation, and chronic pain conditions including CRPS and neuropathic pain. Several Scottsdale providers specialize in integrative and wellness-oriented approaches that combine ketamine therapy with functional medicine, nutritional support, or mindfulness-based practices.